Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release

Figure 2

^aAdjusted mean change from baseline at week 24 LOCF in the proportion of awake time spent “on” during the night and in the early morning (intent-to-treat population).